Prosecution Insights
Last updated: November 20, 2026

Enusha Karunasena, USPTO Patent Examiner

Listed by the USPTO as KARUNASENA, ENUSHA

Tech Center 1700 • Art Units: 1600 1632 1643 1645 1647 1651 1653 1796 1797

This examiner grants 33% of resolved cases

Analysis

KARUNASENA, ENUSHA is a USPTO patent examiner in Tech Center 1700 and Art Unit 1600. The record contains 6 resolved cases, with a 33.3% allowance rate, a 100.0% interview lift, and a median of 1017 days to allowance. The limited sample makes the allowance and interview figures preliminary, although the record associates interviews with improved allowance outcomes.

The recurring companies are Honda Motor Co., Ltd., THE GENERAL HOSPITAL Corporation, and Nestlé S.A. The listed firms are FOLEY & LARDNER LLP, K&L Gates LLP-Nestec S.A., and AMIN, TUROCY & WATSON, LLP. Counsel may consider an interview where it can address a defined prosecution issue, but the 6-case record does not establish a stable pattern. The 1017-day median is best used as an initial timing reference rather than a prediction.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

33.3%
Allow Rate
-31.7% vs TC avg
44
Total Applications
+100.0%
Interview Lift
1017
Avg Prosecution Days
Based on 6 resolved cases, 2023–2026

Rejection Statute Breakdown

9.0%
§101 Eligibility
24.1%
§102 Novelty
30.3%
§103 Obviousness
26.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18555205 DYNAMIC NUTRIENT CONTROL PROCESSES Final Rejection Janssen Biotech, Inc.
18685934 MICROALGAL CULTURE STATE DETERMINATION METHOD Final Rejection HONDA MOTOR CO., LTD.
18726542 CORYNEBACTERIUM TO TREAT OR LIMIT CUTANEOUS WOUND INFECTION Non-Final OA THE GENERAL HOSPITAL CORPORATION
18692462 METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING BUTYRATE AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
18464152 COMBINATION THERAPY FOR INFLAMMATORY DISEASES Final Rejection The United States Government, as Represented by the Department of Veterans Affairs
18712230 LIQUID CARRIER CONCENTRATE COMPRISING AT LEAST ONE BENEFICIAL MICROORGANISM AND USES THEREOF Non-Final OA SPECIALTY OPERATIONS FRANCE
18482990 COMPOSITIONS AND METHODS COMPRISING SERINE PROTEASE VARIANTS Non-Final OA Danisco US Inc.
18704810 AGENT FOR INHIBITING PROLIFERATION OF SARS-CoV-2 Non-Final OA Kirin Holdings Kabushiki Kaisha

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Enusha Karunasena's allowance rate?

33.3% of resolved applications examined by Enusha Karunasena were allowed (6 resolved cases), compared with 36.5% across Art Unit 1600 over the last five years.

Does an interview help with examiner Enusha Karunasena?

This examiner's interview lift is +100.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Enusha Karunasena take to allow a patent?

Applications allowed by Enusha Karunasena took 1,017 days on average from filing to allowance.

Which art unit does examiner Enusha Karunasena work in?

Enusha Karunasena examines applications in Art Unit 1600 in Tech Center 1700 (Chemistry & Materials).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month